发明名称 |
THERAPEUTIC AGENT FOR CANCER |
摘要 |
When functional p53 is expressed in cancer even though the cancer develops SAC dysfunction, a CENP-E inhibitor is effective as a therapeutic agent for the cancer. The sensitivity of cancer to an CENP-E inhibitor can be determined by determining whether or not the cancer develops abnormality in SAC function and determining whether or not functional p53 is expressed in the cancer. |
申请公布号 |
WO2012008507(A1) |
申请公布日期 |
2012.01.19 |
申请号 |
WO2011JP66021 |
申请日期 |
2011.07.13 |
申请人 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED;OHASHI, AKIHIRO |
发明人 |
OHASHI, AKIHIRO |
分类号 |
A61K45/00;A61P35/00;A61P43/00 |
主分类号 |
A61K45/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|